ADARx Pharmaceuticals, Inc. Common Stock (ADRX)

Oct 05, 2026

Simeon George Discloses Investment at ADARx Pharmaceuticals with 9.3% Stake - TradingView

Oct 05, 2026

Oct 03, 2026

ADRX News & Events - Intellectia AI

Oct 03, 2026

Oct 02, 2026

OrbiMed Advisors Discloses Investment at ADARx Pharmaceuticals with 14.0% Stake - TradingView

Oct 02, 2026

Oct 01, 2026

Upcoming & Recent IPO'sIPOs Calendar - ca.finance.yahoo.com

Oct 01, 2026

Oct 01, 2026

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering - FinancialContent

Oct 01, 2026

Sep 30, 2026

Form 4 ADARx Pharmaceuticals For: 30 September By Investing.com - Investing.com South Africa

Sep 30, 2026

Sep 30, 2026

ADARx Pharmaceuticals Director Reports Preferred Stock Conversions and IPO Share Purchase - Kalkine Media

Sep 30, 2026

Sep 30, 2026

At $17 a share, OrbiMed Israel Partners II buys 61,516 IPO shares in ADARx Pharmaceuticals (ADRX). - Stock Titan

Sep 30, 2026

Sep 28, 2026

Options on 170,692 shares at $17 each go to ADARx Pharmaceuticals (ADRX) chief scientific officer. - Stock Titan

Sep 28, 2026

Sep 28, 2026

ADARx Raises $446.3 Million in IPO Priced at $17.00 Per Share - Minichart

Sep 28, 2026

Sep 28, 2026

Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering - Legal Desire

Sep 28, 2026

Sep 25, 2026

ADARx Pharmaceuticals Shares Jump On Nasdaq Debut - Yahoo Finance

Sep 25, 2026

Sep 25, 2026

Another top IPO: Adarx’s $446M to advance clinical siRNA assets - BioWorld News

Sep 25, 2026

Sep 25, 2026

Adarx Pharmaceuticals allocates 55% of IPO to 10 investors By Investing.com - Investing.com

Sep 25, 2026

Sep 25, 2026

Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering - Latham & Watkins LLP

Sep 25, 2026

Sep 25, 2026

Adarx Pharmaceuticals allocates 55% of IPO to 10 investors By Investing.com - Investing.com

Sep 25, 2026

Sep 25, 2026

ADARx Pharmaceuticals, Inc. Common Stock (ADRX) Income StatementYahoo Finance - Yahoo! Finance Canada

Sep 25, 2026

Sep 25, 2026

ADARx Pharmaceuticals Prices Upsized $446.3 Million Initial Public Offering - Yahoo Finance

Sep 25, 2026

Sep 25, 2026

ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public - BioSpace

Sep 25, 2026

Sep 25, 2026

Form S-1 ADARx Pharmaceuticals For: 25 September By Investing.com - Investing.com UK

Sep 25, 2026

Sep 24, 2026

Adarx Pharmaceuticals IPO opens at $22.10, 30% above pricing - scanx.trade

Sep 24, 2026

Sep 24, 2026

Articles from ADARx Pharmaceuticals Inc. - FinancialContent

Sep 24, 2026

Sep 24, 2026

IPO calendar for: - Yahoo Finance Singapore

Sep 24, 2026

Sep 24, 2026

IPO calendar for: - Yahoo Finance Singapore

Sep 24, 2026

Sep 24, 2026

ADARx Pharmaceuticals prices $446.3M IPO at $17 per share - Investing.com

Sep 24, 2026

Sep 24, 2026

ADARx Pharmaceuticals prices upsized IPO at $17 per share - Investing.com

Sep 24, 2026

Sep 24, 2026

ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering - Yahoo Finance

Sep 24, 2026

Sep 24, 2026

Total common shares outstanding of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX - tradingview.com

Sep 24, 2026

Sep 24, 2026

Diluted net income available to common stockholders of ADARx Pharmaceuticals Inc. – NASDAQ:ADRX - tradingview.com

Sep 24, 2026

Sep 22, 2026

ADARx Pharmaceuticals (ADRX): ADARx Sets Terms, Targets Up to $372m in IPO, AbbVie Alongside - Smartkarma

Sep 22, 2026

Sep 21, 2026

ADARx Pharmaceuticals Plans IPO of 21.9M Shares at $15-$17 Each - Yahoo Finance

Sep 21, 2026

Sep 10, 2026

ADARx Pharmaceuticals Seeks IPO On Strong Collaboration Deal With AbbVie (Pending:ADRX) - Seeking Alpha

Sep 10, 2026